MedTrace Logo

Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy

NCT00882375 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 479

Last updated 2012-07-02

No results posted yet for this study

Summary

A comparison of a novel nicotine replacement therapy and placebo treatment in smokers motivated to quit smoking.

Conditions

  • Smoking Cessation

Interventions

DRUG

Nicotine

Nicotine administered using novel NRT user instructions

DRUG

Placebo

Placebo administered using novel NRT user instructions

Sponsors & Collaborators

  • McNeil AB

    lead INDUSTRY

Principal Investigators

  • Elisabeth Kruse, PhD · McNeil AB

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Denmark
  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00882375 on ClinicalTrials.gov